Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 16/20 | 0.38 |
| ▸ | DPP4 | P27487 | 2/20 | 0.34 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.34 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21067661 | 1.00 | ELANE (0.38) | ELANEDPP4DPP8DPP7CTSK | |
| Hydrochloric Acid SCHEMBL5728714 | 0.98 | ELANE (0.38) | ELANEDPP4DPP8DPP7CTSK | |
| SCHEMBL6804849 | 0.86 | ELANE (0.39) | ELANEDPP4DPP8DPP7CTSK | |
| Hydrochloric Acid SCHEMBL6806816 | 0.85 | ELANE (0.39) | ELANEDPP4DPP8DPP7CTSK | |
| Hydrochloric Acid SCHEMBL7129582 | 0.85 | ELANE (0.39) | ELANEDPP4DPP8DPP7CTSK | |
| SCHEMBL2678471 | 0.77 | DPP4 (0.36) | ELANEDPP4DPP8DPP7 | |
| SCHEMBL12734314 | 0.75 | DPP4 (0.37) | ELANEDPP4DPP8DPP7 | |
| SCHEMBL8840142 | 0.75 | PTPN1 (0.39) | ELANEDPP4DPP8DPP7 | |
| SCHEMBL13300000 | 0.74 | ELANE (0.50) | ELANE | |
| Potassium Ion SCHEMBL20532960 | 0.72 | DPP4 (0.36) | ELANEDPP4DPP8DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |